Intermediate-Size Expanded Access Protocol (EAP) for LP352

ClinicalTrials.gov ID: NCT06149663

Public ClinicalTrials.gov record NCT06149663. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Sep 7, 2026, 4:32 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Expanded Access Treatment with LP352 for Patients with Developmental and Epileptic Encephalopathies (DEEs) Who Successfully Completed an LP352 Clinical Trial (Intermediate-Size EAP)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is an intermediate-size expanded access program (EAP) study. The purpose of this EAP is to provide continued access to LP352, an investigational drug product being investigated in participants with DEEs. The EAP study will allow continued treatment with LP352 for eligible participants diagnosed with treatment resistant DEEs who successfully completed an LP352 Clinical Trial (Enrollment by Invitation) or an immediate family member who has the exact same gene mutation resulting in the same DEE epilepsy syndrome phenotype or a patient who previously participated in the lorcaserin EAP.

Study identification

NCT ID: NCT06149663
Recruitment status: Available
Study type: Expanded access
Phase: Not listed
Lead sponsor: Longboard Pharmaceuticals; Industry
Enrollment: Not listed

Conditions and interventions

Conditions

Interventions

LP352 Drug

Drug

Eligibility (public fields only)

Age range: 2 Years to 65 Years
Sex: All
Healthy volunteers: Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Not listed
Primary completion: Not listed
Completion: Not listed
Last update posted: Jan 21, 2025

United States locations

U.S. sites: 19
U.S. states: 14
U.S. cities: 18

Facility	City	State	ZIP	Site status
Rancho Research Institute	Downey	California	90242	Available
University of California Los Angeles (UCLA)	Los Angeles	California	90095	Available
University of California Benioff Childrens Hospital	San Francisco	California	94609	Available
Colorados Childrens Hospital	Aurora	Colorado	80045	Available
Northwest Florida Clinical Research Group	Gulf Breeze	Florida	32502	Available
Research Institute of Orlando	Orlando	Florida	32792	Available
University of Southern Florida	Tampa	Florida	33620	Available
Hawaii Pacific Neuroscience	Honolulu	Hawaii	96817	Available
Northwestern Medicine Feinberg School of Medicine	Chicago	Illinois	60611	Available
Mid-Atlantic Epilepsy and Sleep Center	Bethesda	Maryland	20817	Available
Corewell Health	Grand Rapids	Michigan	49506	Available
Washington University School of Medicine	St Louis	Missouri	63110	Available
New York University (NYU)	New York	New York	10012	Available
Lenox Hill Hospital	New York	New York	10075	Available
University Hospitals Cleveland Medical Center	Cleveland	Ohio	44106	Available
Providence Brain & Spine	Portland	Oregon	97225	Available
Thomas Jefferson University	Philadelphia	Pennsylvania	19107	Available
Children's Neuro Consultants of Austin	Austin	Texas	78757	Available
University of Utah	Salt Lake City	Utah	84132	Available

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06149663, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jan 21, 2025 · Synced Sep 7, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06149663 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →